Health-care drama has now spread to biopharma stocks

Health stocks had another bad day, with investor jitters spreading to the biotech and pharmaceutical sectors, as well.

Investors’ anxiety seemed to have expanded from health retailers, managed care companies and health insurers to include biopharma companies on Thursday. The three biggest losers in the Health Care Select Sector SPDR Fund ETF XLV, +0.01% were Regeneron Pharmaceuticals Inc. REGN, -2.88% , Incyte Corp. INCY, -1.53% and Amgen Inc. AMGN, -2.54%

The health-care ETF slid another 0.2% after falling 3% on Wednesday. It is now down 1% for the year, while the S&P 500 SPX, +0.23% has notched gains of around 16%.

>>> Original Source <<<